BOSTON–( COMPANY CORD)– Myomo, Inc. (NYSE American: MYO) (” Myomo” or the “Business”), a wearable clinical robotics business that provides enhanced performance for those struggling with neurological conditions and upper-limb paralysis, today introduced monetary outcomes for the 3 and 6 months finished June 30, 2024. Financial and functional highlights for the 2nd quarter of 2024 consist of the following (all contrasts are with the 2nd quarter of 2023 unless or else suggested): Item rev.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/myomo-reports-second-quarter-2024-financial-results/
